Trial Profile
ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study
Status:
Not yet recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Corticotropin (Primary)
- Indications Sarcoidosis
- Focus Therapeutic Use
- 25 Jan 2015 Planned initiation date changed from 1 Jun 2014 to 1 Feb 2015 as reported by ClinicalTrials.gov
- 08 Jul 2014 New trial record